Cyteir Therapeutics, Inc. Profile Avatar - Palmy Investing

Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II …

Biotechnology
US, Lexington [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CYT's Analysis
CIK: 1662244 CUSIP: - ISIN: US23284P1030 LEI: - UEI: -
Secondary Listings
CYT has no secondary listings inside our databases.